Company Financials

Repligen Corporation Financials

United States dollar

business Repligen Corporation Company Profile

Main Stock Listing

NASDAQ: RGEN

Market Capitalization $9.25 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 8193.00
Forward PE 78.73
Price to Sales TTM $13.03
Price to Book MRQ $4.43
Enterprise to Revenue 12.95
Enterprise to EBITDA 66.78

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.25%
Operating Margin 6.71%
Return on Assets TTM 1.30%
Return on Equity TTM 0.08%

Income Statement

Revenue TTM $707,889,984
Revenue per Share TTM $12.60
Quarterly Revenue Growth 21.90%
Gross Profit TTM $365,193,984
EBITDA $47,622,000
Net Income to Common TTM $1,738,000
Diluted EPS TTM $0.02
Quarterly Earnings Growth YoY 21.91%

Balance Sheet

Total Cash MRQ $748,747,008
Total Cash per Share MRQ $13.30
Total Debt MRQ $
Total Debt to Equity MRQ 33.07
Current Ratio MRQ 8.36
Book Value per Share MRQ $37.01

Cash Flow

Operating Cash Flow TTM $130,889,000
Levered Free Cash Flow TTM $153,330,368

RGEN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 56,283,321
Float Shares 52,682,512
Avg 10 Volume 508,430
Avg 30 Volume None
Shares Short 4,120,083
Short Ratio 6.06
Short % of Shares 9.87%
% Held by Insiders 6.33%
% Held by Institutions 111.10%

Stock Price Summary

Beta 1.11
Fifty Two Week Low $102.97
Fifty Two Week High $182.52
Fifty Two Week Change 6.27%
Day 50 MA $158.70
Day 200 MA $135.40

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date